|
1
|
Bernier J, Bentzen SM and Vermorken JB:
Molecular therapy in head and neck oncology. Nat Rev Clin Oncol.
6:266–277. 2009. View Article : Google Scholar
|
|
2
|
Bozec A, Peyrade F, Fischel JL and Milano
G: Emerging molecular targeted therapies in the treatment of head
and neck cancer. Expert Opin Emerg Drugs. 14:299–310. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Hummel R, Maurer J and Haier J: MicroRNA:
biogenesis, function and role in rancer. Curr Genomics. 11:537–561.
2010. View Article : Google Scholar
|
|
4
|
Wiemer EA: The role of microRNAs in
cancer: no small matter. Eur J Cancer. 43:1529–1544. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Lu J, Getz G, Miska EA, et al: MicroRNA
expression profiles classify human cancers. Nature. 435:834–838.
2005. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Calin GA and Croce CM: MicroRNA signatures
in human cancers. Nat Rev Cancer. 6:857–866. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Wu BH, Xiong XP, Jia J and Zhang WF:
MicroRNAs: new actors in the oral cancer scene. Oral Oncol.
47:314–319. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Reis PP, Tomenson M, Cervigne NK, Machado
J, Jurisica I and Pintilie M: Programmed cell death 4 loss
increases tumor cell invasion and is regulated by miR-21 in oral
squamous cell carcinoma. Mol Cancer. 10:2382010. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Gottardo F, Liu CG, Ferracin M, et al:
Micro-RNA profiling in kidney and bladder cancers. Urol Oncol.
25:387–392. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Volinia S, Calin GA, Liu CG, et al: A
microRNA expression signature of human solid tumors defines cancer
gene targets. Proc Natl Acad Sci USA. 103:2257–2261. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Hammond SM: MicroRNA therapeutics: a new
niche for antisense nucleic acids. Trends Mol Med. 12:99–101. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Lagos-Quintana M, Rauhut R, Lendeckel W
and Tuschl T: Identification of novel genes coding for small
expressed RNAs. Science. 294:853–858. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Bartel DP: MicroRNAs: genomics,
biogenesis, mechanism, and function. Cell. 116:281–297. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Ruan K, Fang X and Ouyang G: MicroRNAs:
novel regulators in the hallmarks of human cancer. Cancer Lett.
285:116–126. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Farazi TA, Spitzer JI, Morozov P and
Tuschl T: miRNAs in human cancer. J Pathol. 223:102–115. 2011.
View Article : Google Scholar
|
|
16
|
Calin GA, Liu CG, Sevignani C, et al:
MicroRNA profiling reveals distinct signatures in B cell chronic
lymphocytic leukemias. Proc Natl Acad Sci USA. 101:11755–11760.
2004. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Schaefer A, Jung M, Mollenkopf HJ, et al:
Diagnostic and prognostic implications of microRNA profiling in
prostate carcinoma. Int J Cancer. 126:1166–1176. 2010.PubMed/NCBI
|
|
18
|
Schepeler T, Reinert JT, Ostenfeld MS, et
al: Diagnostic and prognostic microRNAs in stage II colon cancer.
Clin Chem. 54:1696–1704. 2008.
|
|
19
|
Zhang B, Pan X, Cobb GP and Anderson TA:
microRNAs as oncogenes and tumor suppressors. Dev Biol. 302:1–12.
2007. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Papagiannakopoulos T, Shapiro A and Kosik
KS: MicroRNA-21 targets a network of key tumor-suppressive pathways
in glioblastoma cells. Cancer Res. 68:8164–8172. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Rossi L, Bonmassar E and Faraoni I:
Modification of miR gene expression pattern in human colon cancer
cells following exposure to 5-fluorouracil in vitro. Pharmacol Res.
56:248–253. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Cheng Y, Ji R, Yue J, et al: MicroRNAs are
aberrantly expressed in hypertrophic heart: do they play a role in
cardiac hypertrophy? Am J Pathol. 170:1831–1840. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Liu X, Cheng Y, Zhang S, Lin Y, Yang J and
Zhang C: A necessary role of miR-221 and miR-222 in vascular smooth
muscle cell proliferation and neointimal hyperplasia. Circ Res.
104:476–487. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Zhu S, Wu H, Wu F, Nie D, Sheng S and Mo
YY: MicroRNA-21 targets tumor suppressor genes in invasion and
metastasis. Cell Res. 18:350–359. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Meng F, Henson R, Wehbe-Janek H, Ghoshal
K, Jacob ST and Patel T: MicroRNA-21 regulates expression of the
PTEN tumor suppressor gene in human hepatocellular cancer.
Gastroenterology. 133:647–658. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Löffler D, Brocke-Heidrich K, Pfeifer G,
et al: Interleukin-6 dependent survival of multiple myeloma cells
involves the Stat3-mediated induction of microRNA-21 through a
highly conserved enhancer. Blood. 15:1330–1333. 2007.PubMed/NCBI
|
|
27
|
Schetter AJ, Leung SY, Sohn JJ, Zanetti
KA, Bowman ED and Yanaihara N: MicroRNA expression profiles
associated with prognosis and therapeutic outcome in colon
adenocarcinoma. JAMA. 299:425–436. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Iorio MV, Ferracin M, Liu CG, et al:
MicroRNA gene expression deregulation in human breast cancer.
Cancer Res. 65:7065–7070. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Nam EJ, Yoon H, Kim SW, Kim H, Kim YT and
Kim JH: MicroRNA expression profiles in serous ovarian carcinoma.
Clin Cancer Res. 14:2690–2695. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Saini S, Majid S, Yamamura S, et al:
Regulatory role of mir-203 in prostate cancer progression and
metastasis. Clin Cancer Res. 17:5287–5298. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Wellner U, Schubert J, Burk UC, et al: The
EMT-activator ZEB1 promotes tumorigenicity by repressing
stemness-inhibiting microRNAs. Nat Cell Biol. 11:1487–1495. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Alder H, Taccioli C, Chen H, et al:
Dysregulation of miR-31 and miR-21 induced by zinc deficiency
promotes esophageal cancer. Carcinogenesis. 33:1736–1744. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Chang KW, Kao SY, Wu YH, et al: Passenger
strand miRNA miR-31(*) regulates the phenotypes of oral cancer
cells by targeting RhoA. Oral Oncol. 49:27–33. 2013.PubMed/NCBI
|
|
34
|
Wu ZS, Wang CQ, Xiang R, et al: Loss of
miR-133a expression associated with poor survival of breast cancer
and restoration of miR-133a expression inhibited breast cancer cell
growth and invasion. BMC Cancer. 12:512012. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Sugimura K, Miyata H, Tanaka K, et al:
Let-7 expression is a significant determinant of response to
chemotherapy through the regulation of IL-6/STAT3 pathway in
esophageal squamous cell carcinoma. Clin Cancer Res. 18:5144–5153.
2012. View Article : Google Scholar : PubMed/NCBI
|
